top of page

Non-Invasive Precision Monitoring of Tumors and Early Cancer Detection Using Methylated Free DNA in Blood



Introducing the All-seeing Eye, a groundbreaking technology that detects methylated circulating cell-free DNA released from tumors undergoing apoptosis, necrosis, and secretion into the bloodstream.


This innovative approach allows for the non-invasive monitoring of cancer progression by capturing these tumor-derived DNA fragments circulating in the blood.


By focusing on the methylation patterns specific to cancer cells, the All-seeing Eye provides a powerful and precise tool for early detection, tracking tumor dynamics, and guiding personalized treatment strategies, revolutionizing the way we approach cancer diagnostics and care.

Comments


Commenting has been turned off.
bottom of page